METABICAL ASSIGNMENT 1. This is an individual assignment. Each student must turn in a one-page worksheet for the Metabical case. Use the template on page 2 of this document. The document may be typed or handwritten. You are welcome to use bullet points. 2. While you may interact with other students on this case‚ the worksheet must be turned in on an individual basis. Your worksheet will impact your class participation grade. 3. The questions under “Points to Ponder” below may be treated as suggested
Premium Health care Advertising Health care provider
METABICAL Problem Statement Cambridge Sciences Pharmaceuticals (CPS) wishes to determine the best possible target market in order to launch Metabical‚ the new weight-loss prescription drug that’s stipulated to be included in their portfolio. Importance of Positioning Strategies It’s important to note that finding the accurate positioning for any product within the market is crucial‚ given that historically when a product is incorrectly placed it tends to lack
Premium Obesity Health care
Desventaja: por la independecia del nicho‚ el precio depende del comportamiento del consumidor. Aprovechar el posicionamiento de Metabical. Ventaja: buena valoración del producto Desventaja: ya que el mercado es bastante amplio‚ los consumidores podrían no pagar por el producto Compared to the competition: Advantage: fixed prices serve as a benchmark for pricing of metabical Disadvantage: The product would be similar to the competition for the consumer. Measure the own value: Advantage: It would
Premium Marketing Competition Market
upcoming U.S product launch of CSP¶s newest prescription drug‚ Metabical. Barbara Printup‚ Senior Director of marketing for Cambridge Sciences Pharmaceuticals (CSP) will be the person who is responsible in the product launch of Metabical which scheduled for January 2009. It was now February 2008‚ and Printup¶s first order of business was to develop a viable positioning strategy and associated marketing communications plan for Metabical. 2.0 Executive Summary Cambridge Science Pharmaceuticals
Premium Marketing Obesity Weight loss
Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss‚ which was the first and only prescription drug to obtain FDA approval. The drug was developed to help aid people in the overweight segment to lose 10 to 30 pounds. Barbara Printup is the marketing director in charge of selecting a price for the new prescription drug. In a study CSP did with Metabical‚ people with a body mass index (BMI) of 28 to 30 had an average weight loss of 26 pounds over a
Premium Obesity Marketing
an age group of 25-54 would have a stronger response rate. Metabical aims to be affordable‚ but since it is a prescription drug that is not covered by most insurance plans‚ individuals with an annual income of $40‚000 or more would be more financial able to cover the costs of the drug. Focusing on potential consumers needs‚ benefits‚ and attitudes can help behaviorally segment the consumer market. The need that the ideal Metabical consumer is looking to achieve should be weight-loss with the
Premium Obesity Weight loss Medical prescription
aware of how excess weight is affecting their well-being. These individuals would likely provide personal encouragement to undergo the Metabical process and move from the “think” to the “do” stage. Metabical’s advertisements also provide the “pull” by providing information that is needed to educate consumers on the benefits and points of differentiation that Metabical offers its customers. Health care professionals provide the “push” for individuals to begin taking a prescription drugs for weight
Premium Marketing Health care Weight loss
1. How does Metabical compare to current weight-loss options? Answer: Metabical is revolutionary product and forecasted to be the first FDA approved prescriptive drug for overweight individuals with weight-loss goals. The previous prescriptive drugs have a negative side effects that out weighed its positives. Metabical‚ on the other hand‚ did not display as many negative effects in its trail runs and thus was being strongly endorsed by the medical community. The current weight-loss drugs can be
Premium Obesity Weight loss Cancer
Mai Nguyen New Product Planning Professor Patton 3/5/14 Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug Case 1. How does Metabical compare to current weight-loss options? There are only several other weight-loss options in the market competing with Metabical. The first is prescription drugs. These are prescribed for use only by obese and severely obese individuals. This meant that only individuals with BMI of over 30 who were prescribed weight-loss drugs
Premium Obesity Medical prescription Drugs
Case Study Metabical Introduction Cambridge Sciences Pharmaceuticals’ (CSP) is international health care company Focus on developing‚ manufacturing and marketing products that treat various deceases Want to enter the market for weight-control products in the US Sucessfully managed to develop Metabical‚ new revolutionary product for weight lost SWOT Analysis Strenghts First prescription drug Has Food and Drug Administration approval Good results in clinical trials and market
Premium